Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Blood Pressure|July 21, 1999
Selective increase of the contractile response to endothelin-1 in subcutaneous arteries from patients with essential hypertensionH Lind, M Adner, D Erlinge, et al.European Journal of Pharmacology|February 5, 1999
Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factorM Malmsjö, D Erlinge, E D Högestätt, et al.Acta Physiologica Scandinavica|March 11, 2000
Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+-sensitive PKC-dependent tyrosine kinase pathwayM Hou, E Pantev, S Möller, et al.European Journal of Pharmacology|August 10, 1993
Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstrictionD Erlinge, L Edvinsson, J Brunkwall, et al.The American Journal of Physiology|October 1, 1993
Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmittersD Erlinge, H Yoo, L Edvinsson, et al.Pharmacology & Toxicology|November 1, 1993
Interactions between cultured bovine arterial endothelial and smooth muscle cells: studies on uptake and degradation of low density lipoproteins by smooth muscle cellsC B Xu, L Stavenow, W Liao, et al.Blood Pressure|June 16, 2000
Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure ratsX H Zhao, X Y Sun, D Erlinge, et al.Biochemical and Biophysical Research Communications|August 15, 1998
Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCRD Erlinge, M Hou, T E Webb, et al.Blood Pressure|June 16, 2000
Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjectsT Nilsson, T Hrafnkelsdóttir, L Edvinsson, et al.Arthritis and Rheumatism|January 1, 1994
Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestationsJ Blomberg, O Nived, R Pipkorn, et al.Pageof 6